Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor

NCT04337606 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG: Chidamide
DRUG: Decitabine
DRUG: Camrelizumab

Sponsor

Chinese PLA General Hospital